| JPMORGAN ETFS(IRL)ICAV-EUROPE RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF EUR (DIST) | RVI EUROPA | 21,07% | 32,04% | · | · |
| JPMORGAN ETFS(IRL)ICAV-EUR ULTRA-SHORT INCOME ACTIVE UCITS ETF EUR (ACC) | MONETARIO EURO PLUS | 2,19% | 10,24% | 9,89% | · |
| JPMORGAN ETFS(IRL)ICAV-GBP ULTRA-SHORT INCOME ACTIVE UCITS ETF GBP (ACC) | MONETARIO EUROPA | 3,01% | 17,64% | 16,40% | · |
| JPMORGAN ETFS(IRL)ICAV-GBP ULTRA-SHORT INCOME ACTIVE UCITS ETF GBP (DIST) | MONETARIO EUROPA | -1,26% | 2,51% | -0,78% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL EM RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (ACC) | RVI EMERGENTES | 52,14% | 65,32% | 37,35% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL EM RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (DIST) | RVI EMERGENTES | 49,10% | 54,62% | · | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL EQUITY MULTI-FACTOR UCITS ETF USD (ACC) | RVI GLOBAL | 22,65% | 41,88% | 60,57% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL HIGH YIELD CORPORATE BOND MULTI-FACTOR ACTIVE UCITS ETF USD (ACC) | RFI GLOBAL HIGH YIELD | 7,40% | 20,60% | 24,04% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL HIGH YIELD CORPORATE BOND MULTI-FACTOR ACTIVE UCITS ETF USD H (ACC) | RFI GLOBAL HIGH YIELD | 7,14% | 20,25% | 26,43% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF EUR H (ACC) | RVI GLOBAL | 30,99% | 61,97% | · | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (ACC) | RVI GLOBAL | 29,28% | 58,31% | 75,75% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (DIST) | RVI GLOBAL | 27,78% | 53,13% | · | · |
| JPMORGAN ETFS(IRL)ICAV-USD EMERGING MARKETS SOVEREIGN BOND UCITS ETF EUR HEDGED (ACC) | RFI EMERGENTES | 11,25% | 18,60% | -2,09% | · |
| JPMORGAN ETFS(IRL)ICAV-USD EMERGING MARKETS SOVEREIGN BOND UCITS ETF USD (ACC) | RFI EMERGENTES | 10,00% | 17,73% | 11,09% | · |
| JPMORGAN ETFS(IRL)ICAV-USD EMERGING MARKETS SOVEREIGN BOND UCITS ETF USD (DIST) | RFI EMERGENTES | 3,66% | -1,09% | -15,49% | · |
| JPMORGAN ETFS(IRL)ICAV-USD IG CORPORATE BOND ACTIVE UCITS ETF EUR H (ACC) | DEUDA PRIVADA USA | 5,12% | 9,21% | · | · |
| JPMORGAN ETFS(IRL)ICAV-USD IG CORPORATE BOND ACTIVE UCITS ETF USD (ACC) | DEUDA PRIVADA USA | 3,81% | 8,23% | 5,56% | · |
| JPMORGAN ETFS(IRL)ICAV-USD IG CORPORATE BOND ACTIVE UCITS ETF USD (DIST) | DEUDA PRIVADA USA | -1,47% | -7,05% | -18,89% | · |
| JPMORGAN ETFS(IRL)ICAV-USD ULTRA-SHORT INCOME ACTIVE UCITS ETF USD (ACC) | MONETARIO USA PLUS | 1,06% | 8,37% | 21,35% | · |
| JPMORGAN ETFS(IRL)ICAV-USD ULTRA-SHORT INCOME ACTIVE UCITS ETF USD (DIST) | MONETARIO USA PLUS | -3,19% | -5,93% | 2,51% | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (ACC) | RVI USA | 30,77% | 65,04% | 84,09% | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (DIST) | RVI USA | 29,82% | 61,83% | 77,10% | · |
| JPM PACIFIC EQUITY C (ACC) EUR | RVI ASIA | 39,13% | 43,69% | 23,66% | · |
| JPM PACIFIC EQUITY I2 (ACC) EUR | RVI ASIA | 39,59% | 44,81% | 25,10% | · |
| JPM PACIFIC EQUITY I2 (ACC) USD | RVI ASIA | 39,56% | 45,15% | 25,05% | · |
| JPM SGD LIQUIDITY LVNAV E (ACC) | MONETARIO INTERNACIONAL - OTROS | 1,20% | · | · | · |
| JPM SGD LIQUIDITY LVNAV E (DIST) | MONETARIO INTERNACIONAL - OTROS | -0,31% | · | · | · |
| JPM TAIWAN I (ACC) USD | RVI CHINA | 132,41% | 160,02% | 135,44% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | BIOTECNOLOGÍA | 46,86% | 8,78% | -22,47% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 48,32% | 8,72% | -30,21% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | BIOTECNOLOGÍA | 45,76% | 5,95% | -24,36% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | BIOTECNOLOGÍA | 46,85% | 8,76% | -22,50% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 48,24% | 8,48% | -30,52% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | BIOTECNOLOGÍA | 45,69% | 5,72% | -24,68% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | BIOTECNOLOGÍA | 47,72% | 10,60% | -20,34% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 49,11% | 10,32% | -28,57% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | BIOTECNOLOGÍA | 46,54% | 7,50% | -22,56% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | BIOTECNOLOGÍA | 47,18% | 9,57% | -21,18% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 48,58% | 9,31% | -29,32% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | BIOTECNOLOGÍA | 45,99% | 6,48% | -23,41% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 48,92% | 10,02% | -28,87% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | BIOTECNOLOGÍA | 46,37% | 7,22% | -22,89% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | BIOTECNOLOGÍA | 45,69% | 6,28% | -23,60% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 46,81% | 5,48% | -33,66% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | BIOTECNOLOGÍA | 44,23% | 2,62% | -28,32% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 49,17% | 10,46% | -28,42% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | 46,61% | 7,64% | -22,42% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | 46,46% | 7,10% | -22,70% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 49,02% | 10,16% | -28,73% | · |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 20,34% | 16,77% | 2,09% | · |
